GH

Guardant Health
NASDAQ
31.48
+0.41
+1.30%
Closed 16:07 01/27 EST
OPEN
30.74
PREV CLOSE
31.07
HIGH
31.88
LOW
30.59
VOLUME
1.00M
TURNOVER
--
52 WEEK HIGH
78.34
52 WEEK LOW
24.63
MARKET CAP
3.22B
P/E (TTM)
-5.3027
1D
5D
1M
3M
1Y
5Y
ClearBridge Multi Cap Growth Strategy Q4 2022 Portfolio Manager Commentary
Seeking Alpha · 5d ago
ClearBridge Aggressive Growth Strategy Q4 2022 Portfolio Manager Commentary
Seeking Alpha · 01/22 04:15
Guardant Health: Positive ECLIPSE Data Signals More Upside
Seeking Alpha · 01/20 13:25
Guardant Health And The Royal Marsden NHS Foundation Trust Partner On Highly Anticipated TRACC Part C Trial To Use Guardant Reveal Blood Test To Help Guide Treatment Decisions In Colorectal Cancer
Benzinga · 01/19 13:07
Invitae: What Happened At The JP Morgan Health Conference
Seeking Alpha · 01/19 11:41
Natera, Myriad upgraded as Raymond James reviews genetic testing space
Seeking Alpha · 01/18 14:58
Guardant Health To Showcase New Data At Asco Gi 2023 Demonstrating Utility Of Its Blood Tests For Patients With Gastrointestinal Cancers
Benzinga · 01/17 21:12
Cathie Wood Makes This Molecular Diagnostics Company Top Holding Of Ark Invest's Flagship Fund, Catapulting Past Zoom, Tesla
Benzinga · 01/11 16:19
More
About GH
Guardant Health, Inc. is a precision oncology company. The Company is focused on helping conquer cancer through the use of its blood-based tests, data sets, and advanced analytics. It has developed its Guardant360, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced-stage cancer. It also developed its Guardant Reveal liquid biopsy-based test for residual and recurring cancer to address the need for Stage II-II I colorectal cancer. Its Guardant360 test is a molecular diagnostic test measuring 74 cancer-related genes. Its Guardant360 CDx test is a liquid biopsy test measuring 55 cancer-related genes. Its GuardantOMNI test has a broader 500-gene panel, all of which analyze circulating tumor deoxyribonucleic acid (DNA) in the blood. The Company's tests are used by biopharmaceutical companies for a range of applications, including identifying patient populations to accelerate translational science research and clinical trial enrollment, and companion diagnostic.

Webull offers kinds of Guardant Health Inc stock information, including NASDAQ:GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.